Rapid In Vivo Screening of Experimental Drugs for Tuberculosis Using Gamma Interferon Gene-Disrupted Mice

We have developed a rapid new in vivo method for screening experimental drugs for their activity against Mycobacterium tuberculosis by using the gamma interferon gene-disrupted (GKO) C57BL/6 mouse. Due to the rapid growth of the infection, statistical differences indicating positive efficacy of acti...

Description complète

Détails bibliographiques

Publié dans:	Antimicrob Agents Chemother
Auteurs principaux:	Lenaerts, Anne J. M., Gruppo, Veronica, Brooks, Jason V., Orme, Ian M.
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 2003
Sujets:	Experimental Therapeutics
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC151769/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12543692/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.2.783-785.2003
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!